Article Information
History
- August 4, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Christopher N. Davis1,2,*,
- Kat S. Rock1,2,
- Marina Antillón3,
- Erick Mwamba Miaka4 and
- Matt J. Keeling1,2,5
- 1Mathematics Institute, University of Warwick, Coventry, CV4 7AL, UK
- 2Zeeman Institute (SBIDER), University of Warwick, Coventry, CV4 7AL, UK
- 3Swiss Tropical and Public Health Institute (Swiss TPH), Basel, Switzerland
- 4Programme National de Lutte contre la Trypanosomiase Humaine Africaine (PNLTHA), Ave Coisement Liberation et Bd Triomphal No 1, Commune de Kasavubu, Kinshasa, DRC
- 5School of Life Sciences, University of Warwick, Coventry, CV4 7AL, UK
- ↵*Corresponding author: C.Davis.7{at}warwick.ac.uk
Posted August 04, 2020.
Cost-effectiveness modelling to optimise active screening strategy for gambiense human African trypanosomiasis in the Democratic Republic of Congo
